How We Present
Encouraging findings in Norwegian study on fibromyalgia and Maharishi Ayurveda
by Global Good News staff writer
Global Good News Translate This Article
22 December 2011
A new study is coming out on the use of Maharishi Ayurveda health care in the treatment of fibromyalgia, a condition of widespread chronic pain. This is the second study to be published on this topic by Dr Lars Rasmussen, who has worked in Maharishi Ayurveda in Norway for 20 years. It reports on a 24-month follow-up pilot study on the treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway.
The treatment programmes offered at the Maharishi Ayurveda Health Centre are based on the consciousness-based revival by Maharishi Mahesh Yogi of the ancient Ayurvedic medicine tradition in India, which is known as Maharishi Ayurveda.
The new study follows an earlier one Dr Rasmussen published in 2009 in Clinical and Experimental Rheumatology, which reported on a 6-month follow-up study on the same subject. The objective of the first study, as stated in the abstract, was 'to conduct a pilot study of the effect of the treatment program at the Health Centre on fibromyalgia patients'.
The 2009 study involved 31 women with diagnosed fibromyalgia, each of whom received a customized Maharishi Ayurveda treatment plan, including physiological purification (Panchakarma), a specialized Ayurvedic diet, and structured daily routines.
The participants were also offered instruction in the Transcendental Meditation Technique (TM) 'for stress and pain management and personal development', which four subjects learned; they were also given recommendations for Ayurvedic herbal food products for home treatment.
By the end of the six-month follow-up period after their treatment, symptoms like working ability, pain, tiredness, stiffness, anxiety, and depression were all reduced.
A group of five participants, 'including all four participants who started to practise TM, had almost no symptoms by the endpoint'. Compared to the non-meditating control group, the TM-subgroup showed statistically significant improvements on all but one of the outcome measures.
Based on these positive findings which showed improvement following the Maharishi Ayurveda treatments, the first study concluded, 'Because fibromyalgia is considered a treatment-resistant condition, these encouraging results warrant further research.'
Global Good News will report on findings of the new study published by Dr Rasmussen and colleagues.
© Copyright 2012 Global Good News®
Global Good News comment:
For the good news about Maharishi's seven-point programme to create a healthy, happy, prosperous society, and a peaceful world, please visit: Global Financial Capital of New York.
Translation software is not perfect; however if you would like to try it, you can translate this page using: